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Summary: Serum total sialic acid has gained recent interest äs a cardiovascular risk factor. We measured serum
total sialic acid and three acute phase proteins; C-reactive protein, arantichymotrypsin and <xracid glycoprotein in
37 geriatric patients (age 80.1 ± 7.0 years) and 50 younger subjects (age 40.3 ±11.4 years). Serum total sialic
acid was higher in the geriatric subjects 2.41 ± 0.39 mmol/1 versus 2.04 ± 0.35 mmol/1, P < 0.04. Serum
 {-acid
glycoprotein, cti-antichymotrypsin and C-reactive protein were also elevated in the geriatric patients; serum a!-acid
glycoprotein being 1.16 ± 0.32 g/l versus 0.41 ± 0.28 g/l, P < 0.0001, serum arantichymotrypsin being 0.80
± 0.20 g/l versus 0.52 ± 0.10 g/l, P < 0.0001 and serum C-reactive protein being 9.71 ± 21.0 mg/1 versus 4.73
± 1.30 mg/1, P < 0.04. There was a correlation with serum total sialic acid and serum aracid glycoprotein and ar
antichymotrypsin in the geriatric subjects and with -acid glycoprotein, arantichymotrypsin and C-reactive protein
in the younger group.
Introdüction
Increased serum total sialie acid has been shown to be
a cardiovascular risk factor (l, 2) and also a cerebrovas-
cular risk factor (3). Serum total sialic acid is elevated
in diabetes mellitus (4—6), after myocardial infarction
(7, 8) in patients with chronic glomenilonephritis (9)
and inflammatory bowel disease (10). Serum total sialic
acid has also been used äs a tumour marker for a number
of different caneers, including malignant melanoma,
breast and colon carcinoma (11 — 14). It has been sug-
gested that elevated serum total sialic acid may reflect
an acute phase response (15). Many of the serum acute
phase proteins are glycoproteins and some have sialic
acid residues located within their carbohydrate side-
chains. Although there have been several studies of se-
rum total sialic acid in ypung and rniddle aged human
populations (16—17) there have been few studies that
have evaluated serum total sialic acid concentrations in
the elderly.
Methods
Subjects
Thirty-seven patients frorn a psychogeriatric hospital (age 80.1
± 7.0 years) were studied and also fifty younger aged subjects
(40.3 ±11.4 years). Geriatric patients with diabetes mellitus (äs
judged by random blood glucose concentration of more than 11.1
mmol/1), known infection or tumour, cardiovascular disease, recent
operations or any other known causes of an acute phase response
were excluded by relevant clinical history and physical examina-
tion. In the geriatric group there were 18 females and 19 males,
whereas in the younger aged group there were 27 females and 23
males. There was no difference in the proportion of the sexes be-
tween the two groups. The younger subjects were either healthy
blood donors or normal individuals who were part of a health
screening program. None of the subjects had diabetes mellitus (ran-
dom blood glucose of less than 11.1 mmol/1) and they also had
no recent infections, myocardial infarctions, operations or known
malignant disease.
Serum total sialic acid, albumin and total protein along with the
acute phase proteins: C-reactive protein, -acid glycoprotein and
aj-antichymotrypsin were assayed upon the same blood sample.
Serum globulin concentration was calculated äs the difference be-
tween serum total protein and serum albumin concentrations.
Assays
Serum total sialic acid was assayed using an enzymatic method
purchased from Boehringer Mannheim, (Lewes, Sussex, England)
on a Röche Cobas Bio analyser. This method uses a coupled en-
zyme assay reaction, incorporating neuraminidase, N-acetylneu-
raminic acid aldolase and pyruvate oxidase linked to a peroxidase
dye systern. The intra-batch coefficient of Variation was 3.8%. The
serum acute phase proteins were assayed immunoturbidimetrically,
using commercial kits from Binding Site (Binding Site Ltd, Bir-
mingham, UK) on a Cobas Mira analysen Serum albumin and total
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protein were assayed using a Kodak Ektachem analyser (Kodak
Ltd, USA).
Statistics
Results are shown äs mean ± Standard deviation. DifFerences be-
tvveen groups were compared using the Mann-Whitney test and the
degree of correlation by using the Spearman correlation coefficient
(rho). Significance was taken äs P being less than 0.05.
Results
Subject age, sex distribution and serüm total sialic acid
and acute phase pröteins are depicted in table 1. There
was a significant difference in serum total sialic acid
between the two groups being higher in the geriatric
subjects. Serum aracid glycoprotein, arantichymotryp-
sin and C-reactive protein were significantly elevated in
the geriatric patients äs compared to the younger aged
group. Serum albumin was significantly lower in the
geriatric subjects, whereas, the serum globulin concen-
tration was elevated in the geriatric subjects.
Serum total sialic acid correlated significantly with se-
rum C-reactive protein, arantichymotrypsin and aracid
glycoprotein in the younger aged subjects büt only with
serum c^-antichymotrypsin and weakly with aracid
glycoprotein in the geriatric group. Spearman correla-
tion coefficients and statistical significance for the geri-
atric and younger aged subjects are depicted in table 2.
Tab. l Age, serum sialic acid and acute phase pröteins for the
geriatric and younger subjects. H-P < 0.04, *P<0.0001. The
ranges for the data are shown in parentheses.
Tab. 2 Spearman correlation coefficierits (r) and statistical signi-
ficance (p) for serum total sialic acid against serum acute phase
pröteins for the geriatric and younger subjects.
Age (years)
Sex (9/c?)
Serum total sialic acid
(mmol/1)
C-reactive protein
(mg/1)
arAcid glycoprotein
(g/0
- Antichymotrypsin
(g/l)
Albumin (g/l)
Protein (g/l)
Globulin (g/l)
Geriatric subjects
80.1 ± 7.0
18?/19<J
2.41 ± 0.39
(1.6 - 3.7)
9.71 ± 21.0
(1 - 123.5)
1.16 ± 0.32
(0.73 - 2.03)
0.80 ± 0.20
(0.40- 1.45)
36.9 ± 3.1
(31.0 - 43.0)
70.3 ± 7.0
(58.0 - 86.0)
33.5 ± 5.2
(24.0 - 43.0)
Younger subjects
40.3 ±11.4
27?/23cJ
2.04 ± 0.35+
(1.2 - 2.7)
4.73 ± 1.30+
(3.5 - 12.1)
0.41 ± 0.28*
(0.17- 0.95)
0.52 ± 0.10*
(0.29- 0.74)
43.8 ± 3.7*
(34.0 -52.0)
71.3 ± 5.3
(59.0 -80,0)
28.0 ± 3.7* ·
(17.0 -35.0)
C-reactive
protein
r Acid
glyco-
protein
ai-Anti-
chymor
trypsin
Albumin
Protein
Globulin
Geriatric subjects
r- 0.10 p = 0.28
• r
r= 0.32 p = 0.03
r= 0.48 p = 0.001
r = -0.01 p = 0.49
r= 0.06 p = 0.36
r?= 0.09 p = 0.29
Younger subjects
r = 0.61 p < 0.0001
r= 0.29 p = 0.03
r = 0.79 p < 0.0001
r = ~o.05 p = 0.38
r- 0.11 p = 0.24
r = 0.18 p = 0.12
Discussion
Although we accept that it is very difficult to exclude
underlying organic pathology in psychogeriatric patients
we were cafeful to eliminate individuäls with conditions
known to elicit an acute phase protein response. In any
case it would be equally difficult to exclude conditions
causing an acute phase response in any group of geriat-
ric subjects. The underlying mechanism for the elevation
of serum total sialic acid in elderly subjects may be due
to a concomitant elevation of serum acute phase pröteins
many of which are known to be sialylated. Further sup-
port of this hypothesis eomes from the significant corre-
lation between serum total sialic acid and some of the
acute phase pröteins, namely serum ai-antichymotiypsin
and ai-acid glycoprotein in the geriatric subjects and
serum C-reactive protein, tti-antichymotrypsin aiid -
acid glycoprotein in the younger subject group. We ex-
cept, however, that these correlations are weak particu-
larly in the geriatric subjects.
The three positive acute phase pröteins measured in our
study were chosen for the following reasons; aracid
glycoprotein is a richly sialylated glycoprotein, serum
C-reactive protein is elevated for a short time äs a result
of an acute phase protein response, whereas the serum
-antichymotrypsin response tends to be proloiiged. We
should state, however, that C-reactive protein is not
thought to be sialylated (18). Our findings also support
those of Taniuchi et al. (15) who found that serum total
sialic acid was related to some of the acute phase prö-
teins in subjects after a myocardial infarction. Further-
more, our obseirvations expand upon those of Milman
and co-workers who earlier reported that erythrocyte
Sedimentation rate, fibrinogen, haptoglobin and -anti-
trypsin were also elevated in the elderly (19). However,
these workers did not measure serum sialic acid in their
stüdy. We should state, however, that serum total siaäic
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acid was only moderately elevated in the elderly sub-
jects and there was some overlap in the serum total sialic
acid ranges between the two groups. The explanation is
unclear but may reflect heterogeneity of levels of acute
phase proteins or differing degrees of glycoprotein sialy-
lation in these individuals.
Serum total sialic acid is likely to be measured more
frequently in hospital practice. The novel fmdings pre-
sented in this paper suggest that age considerations
should be made when attempting to Interpret serum total
sialic acid levels. We can only speculate äs to why the
serum acute phase proteins are elevated in the elderly,
but presumably they are more likely to have atheroscle-
rosis than a younger population and Stuart and co-
workers have shown that this can result in an elevation
of serum acute phase proteins (20).
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